chr17-7217739-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000399510.8(DLG4):c.159+502T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000292 in 1,534,904 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00066 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00025 ( 1 hom. )
Consequence
DLG4
ENST00000399510.8 intron
ENST00000399510.8 intron
Scores
1
1
12
Clinical Significance
Conservation
PhyloP100: -0.287
Genes affected
DLG4 (HGNC:2903): (discs large MAGUK scaffold protein 4) This gene encodes a member of the membrane-associated guanylate kinase (MAGUK) family. It heteromultimerizes with another MAGUK protein, DLG2, and is recruited into NMDA receptor and potassium channel clusters. These two MAGUK proteins may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signaling proteins. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
ACADVL (HGNC:92): (acyl-CoA dehydrogenase very long chain) The protein encoded by this gene is targeted to the inner mitochondrial membrane where it catalyzes the first step of the mitochondrial fatty acid beta-oxidation pathway. This acyl-Coenzyme A dehydrogenase is specific to long-chain and very-long-chain fatty acids. A deficiency in this gene product reduces myocardial fatty acid beta-oxidation and is associated with cardiomyopathy. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.005048126).
BS2
High AC in GnomAd4 at 101 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACADVL | NM_001270447.2 | c.52A>G | p.Ile18Val | missense_variant | 2/21 | ||
DLG4 | NM_001321074.1 | c.159+502T>C | intron_variant | ||||
DLG4 | NM_001365.4 | c.159+502T>C | intron_variant | ||||
DLG4 | NR_135527.1 | n.1360+502T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DLG4 | ENST00000399510.8 | c.159+502T>C | intron_variant | 1 | |||||
ACADVL | ENST00000543245.6 | c.52A>G | p.Ile18Val | missense_variant | 2/21 | 2 | |||
DLG4 | ENST00000648172.8 | c.159+502T>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000665 AC: 101AN: 151888Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
101
AN:
151888
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000320 AC: 41AN: 128324Hom.: 0 AF XY: 0.000299 AC XY: 21AN XY: 70286
GnomAD3 exomes
AF:
AC:
41
AN:
128324
Hom.:
AF XY:
AC XY:
21
AN XY:
70286
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000251 AC: 347AN: 1383016Hom.: 1 Cov.: 31 AF XY: 0.000262 AC XY: 179AN XY: 682436
GnomAD4 exome
AF:
AC:
347
AN:
1383016
Hom.:
Cov.:
31
AF XY:
AC XY:
179
AN XY:
682436
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000665 AC: 101AN: 151888Hom.: 0 Cov.: 30 AF XY: 0.000957 AC XY: 71AN XY: 74190
GnomAD4 genome
AF:
AC:
101
AN:
151888
Hom.:
Cov.:
30
AF XY:
AC XY:
71
AN XY:
74190
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | ACADVL: PP3 - |
Primary familial hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Blueprint Genetics | Nov 19, 2014 | - - |
Very long chain acyl-CoA dehydrogenase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Mar 08, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Uncertain
T
MutationTaster
Benign
N;N;N
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Vest4
MutPred
Gain of ubiquitination at K16 (P = 0.0918);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at